mRNA vaccine encoding tumor-specific circular RNA antigens
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for mRNA vaccine encoding tumor-specific circular RNA antigens, covering 2025-11-24 to 2025-11-24. Get the full timeline:
Most recent: Clinical Trial Update: Safety and Tolerability of a mRNA Vaccine Encoding Tumor-Specific Circular RNA Antigens in Combination With Anti-PD-1 Monoclonal Antibody in Patients With Advanced Solid Tumors [Phase 1, Phase 2]